Načítá se...
Hypoxia-inducible factors as molecular targets for liver diseases
Liver disease is a growing global health problem, as deaths from end-stage liver cirrhosis and cancer are rising across the world. At present, pharmacologic approaches to effectively treat or prevent liver disease are extremely limited. Hypoxia-inducible factor (HIF) is a transcription factor that r...
Uloženo v:
| Vydáno v: | J Mol Med (Berl) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4879168/ https://ncbi.nlm.nih.gov/pubmed/27094811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-016-1408-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|